TearLab Corp

Find Ratings Reports
TEAR : NASDAQ : Health Care
$2.95 up 0.08 | 2.8%
Today's Range: 2.7 - 3.0101
Avg. Daily Volume: 526200.0
07/26/17 - 3:59 PM ET

Financial Analysis


TEARLAB CORP's gross profit margin for the first quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. Even though sales decreased, the net income has increased. TEARLAB CORP is extremely liquid. Currently, the Quick Ratio is 2.22 which clearly shows the ability to cover any short-term cash needs. The company managed to increase its liquidity from the same period a year ago, despite already having strong liquidity to begin with. This would indicate improved cash flow.

During the same period, stockholders' equity ("net worth") has increased by 6.00% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)6.76.77
EBITDA ($mil)-2.85-5.23
EBIT ($mil)-3.39-6.16
Net Income ($mil)-4.42-7.25


Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)13.037.2
Total Assets ($mil)23.9821.45
Total Debt ($mil)26.9125.2
Equity ($mil)-9.82-10.45


Profitability Q1 FY17 Q1 FY16
Gross Profit Margin63.1163.59
EBITDA Margin-42.59-77.24
Operating Margin-50.59-91.04
Sales Turnover1.171.24
Return on Assets-71.24-150.64
Return on Equity0.00.0
Debt Q1 FY17 Q1 FY16
Current Ratio2.882.26
Debt/Capital1.571.71
Interest Expense1.030.88
Interest Coverage-3.3-6.98


Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)5.643.42
Div / share0.00.0
EPS-0.82-2.1
Book value / share-1.74-3.05
Institutional Own % n/a n/a
Avg Daily Volume122662.0154336.0

Valuation


SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. Along with this, the price-to-book ratio is also meaningless due to a negative book value for the company, making any comparisons useless. The price-to-sales ratio is well below both the S&P 500 average and the industry average, indicating a discount.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
TEAR NM Peers 47.54   TEAR NM Peers 29.38

Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.

TEAR's P/E is negative making this valuation measure meaningless.

 

Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

TEAR's P/CF is negative making the measure meaningless.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
TEAR NA Peers 25.74   TEAR NA Peers 0.99

Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential.

Ratio not available.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
TEAR NM Peers 5.47   TEAR 65.06 Peers 113.75

Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

TEAR's P/B is negative making this valuation measure meaningless.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, TEAR is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
TEAR 0.35 Peers 5.22   TEAR 5.40 Peers 14.04

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

TEAR is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

TEAR significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades